However, GLP-1 trends are reshaping diabetes & obesity care with real-world data on adoption, outcomes & future drugs in 2025, according to the HealthVerity Blog
Although no significant change in depressive symptoms was observed, the treatment group showed a significant improvement in anxiety symptoms compared with the other group
Other at-risk populations include individuals on chronic steroids, which cause muscle wasting, patients unable to engage in strength and resistance training, or patients with muscle-wasting conditions like chronic kidney disease. McGowan also noted that even healthy individuals should expect some muscle loss
Parents should also be looped into any conversations with a pediatrician about risks, side effects, and healthy lifestyle changes that are associated with the medications
[Abstract] CD4 + T cells from SLE patient were treated with TNF-, IL-6, E2, LPS, UVB, prednisolone (10 ng/ml, 24 h) in vitro